Related Experiment Video
Updated: Jan 30, 2026

Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
Published on: July 28, 2023
Ganoderic Acid A Modulates Enteric Neurons and Intestinal Homeostasis in Irritable Bowel Syndrome by Microbiota
Rong-Wei Kou1, Rui-Jing Zhang2, Bing Xia3
1Department of Applied Chemistry, Xi'an University of Technology, Xi'an 710054, Shaanxi, People's Republic of China.
Ganoderic acid A (GAA) from Ganoderma lucidum alleviates irritable bowel syndrome (IBS) symptoms by modulating gut bacteria and enteric neurons. This study reveals GAA
Area of Science:
- Gastroenterology and Pharmacology
- Microbiology and Immunology
Background:
- Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder marked by visceral hypersensitivity and dysmotility.
- Ganoderic acid A (GAA), a triterpenoid from Ganoderma lucidum, has known health benefits, but its effect on IBS is unexplored.
Purpose of the Study:
- To investigate the therapeutic potential of Ganoderic acid A (GAA) in a mouse model of irritable bowel syndrome (IBS).
- To elucidate the underlying mechanisms of GAA's action, focusing on gut microbiota, enteric neurons, and intestinal homeostasis.
Main Methods:
- An IBS-like phenotype was induced in C57BL/6 mice using Citrobacter rodentium challenge and water avoidance stress.
- Mice were supplemented with GAA, and outcomes were assessed by measuring IBS symptoms, intestinal motility, neuronal activity, inflammation, barrier integrity, and mast cell activity.
- Gut microbiota composition, tryptophan metabolism, and aryl hydrocarbon receptor (AhR) signaling were analyzed. Antibiotic treatment was used to confirm microbiota dependence.
Main Results:
- GAA supplementation significantly alleviated IBS-like symptoms, improving intestinal motility and reducing visceral hypersensitivity.
- GAA normalized enteric nNOS+ and ChAT+ neurons, reduced colonic inflammation, reinforced epithelial barrier integrity, and normalized mast cell activity.
- GAA modulated the gut microbiota, promoted indole-3-aldehyde (IAld) production via tryptophan-metabolizing bacteria, activating AhR signaling. These benefits were abolished by antibiotic treatment.
Conclusions:
- Ganoderic acid A (GAA) demonstrates significant therapeutic effects against IBS-like symptoms in mice.
- GAA acts through a microbiota-sensing mechanism, influencing gut bacteria, tryptophan metabolism, and AhR signaling to restore intestinal homeostasis.
- These findings highlight GAA as a potential nutritional strategy for managing IBS and related gastrointestinal disorders.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
What is Homeostasis?
pH Homeostasis
Respiratory...
Skeleton and Calcium Homeostasis

